The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...

Inspire Medical Systems has issued a recall for the Inspire IV Implantable Pulse Generator (IPG) Model 3028 because of a manufacturing defect that could disrupt therapy and cause serious adverse ...

Baptista P, et al. (2022). Quality of life impact of hypoglossal nerve stimulation with Inspire® device in patients with obstructive sleep apnea intolerant to continuous positive airway pressure ...

The Inspire device delivers what's called "hypoglossal nerve stimulation therapy" while you sleep. Previously it was connected to two places in your body -- the hypoglossal nerve and your ribs.

Inspire Sleep Apnea Therapy is a relatively new treatment for OSA, founded in 2007. The FDA-approved treatment involves a small implant being placed near your collarbone to assist your breathing ...

A high-level overview of Inspire Medical Systems, Inc. (INSP) stock. View (INSP) real-time stock price, chart, news, analysis, analyst reviews and more.

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s INSP nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its IV ...